Interpreting MYC and BCL2 in diffuse large B-cell lymphoma

被引：4
作者：
Lai, Catherine [1 ]
Grant, Cliona [1 ]
Dunleavy, Kieron [1 ]
机构：
[1] NCI, Ctr Canc Res, Bethesda, MD 20892 USA
来源：
LEUKEMIA & LYMPHOMA | 2013年 / 54卷 / 10期
关键词：
RITUXIMAB PLUS CYCLOPHOSPHAMIDE; POOR-PROGNOSIS; C-MYC; VINCRISTINE; DOXORUBICIN; PREDNISONE; EXPRESSION;
D O I：
10.3109/10428194.2013.806803
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：2091 / 2092
页数：2
相关论文
共 10 条
  • [1] Rearrangement of MYC Is Associated With Poor Prognosis in Patients With Diffuse Large B-Cell Lymphoma Treated in the Era of Rituximab
    Barrans, Sharon
    Crouch, Simon
    Smith, Alex
    Turner, Kathryn
    Owen, Roger
    Patmore, Russell
    Roman, Eve
    Jack, Andrew
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (20) : 3360 - 3365
  • [2] HUMAN C-MYC ONC GENE IS LOCATED ON THE REGION OF CHROMOSOME-8 THAT IS TRANSLOCATED IN BURKITT-LYMPHOMA CELLS
    DALLAFAVERA, R
    BREGNI, M
    ERIKSON, J
    PATTERSON, D
    GALLO, RC
    CROCE, CM
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1982, 79 (24): : 7824 - 7827
  • [3] Non-transcriptional control of DNA replication by c-Myc
    Dominguez-Sola, David
    Ying, Carol Y.
    Grandori, Carla
    Ruggiero, Luca
    Chen, Brenden
    Li, Muyang
    Galloway, Denise A.
    Gu, Wei
    Gautier, Jean
    Dalla-Favera, Riccardo
    [J]. NATURE, 2007, 448 (7152) : 445 - U3
  • [4] Immunohistochemical Double-Hit Score Is a Strong Predictor of Outcome in Patients With Diffuse Large B-Cell Lymphoma Treated With Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone
    Green, Tina Marie
    Young, Ken H.
    Visco, Carlo
    Xu-Monette, Zijun Y.
    Orazi, Attilio
    Go, Ronald S.
    Nielsen, Ole
    Gadeberg, Ole V.
    Mourits-Andersen, Torben
    Frederiksen, Mikael
    Pedersen, Lars Moller
    Moller, Michael Boe
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (28) : 3460 - 3467
  • [5] MYC status in concert with BCL2 and BCL6 expression predicts outcome in diffuse large B-cell lymphoma
    Horn, Heike
    Ziepert, Marita
    Becher, Claudia
    Barth, Thomas F. E.
    Bernd, Heinz-Wolfram
    Feller, Alfred C.
    Klapper, Wolfram
    Hummel, Michael
    Stein, Harald
    Hansmann, Martin-Leo
    Schmelter, Christopher
    Moeller, Peter
    Cogliatti, Sergio
    Pfreundschuh, Michael
    Schmitz, Norbert
    Truemper, Lorenz
    Siebert, Reiner
    Loeffler, Markus
    Rosenwald, Andreas
    Ott, German
    [J]. BLOOD, 2013, 121 (12) : 2253 - 2263
  • [6] Concurrent Expression of MYC and BCL2 in Diffuse Large B-Cell Lymphoma Treated With Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone
    Johnson, Nathalie A.
    Slack, Graham W.
    Savage, Kerry J.
    Connors, Joseph M.
    Ben-Neriah, Susana
    Rogic, Sanja
    Scott, David W.
    Tan, King L.
    Steidl, Christian
    Sehn, Laurie H.
    Chan, Wing C.
    Iqbal, Javeed
    Meyer, Paul N.
    Lenz, Georg
    Wright, George
    Rimsza, Lisa M.
    Valentino, Carlo
    Brunhoeber, Patrick
    Grogan, Thomas M.
    Braziel, Rita M.
    Cook, James R.
    Tubbs, Raymond R.
    Weisenburger, Dennis D.
    Campo, Elias
    Rosenwald, Andreas
    Ott, German
    Delabie, Jan
    Holcroft, Christina
    Jaffe, Elaine S.
    Staudt, Louis M.
    Gascoyne, Randy D.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (28) : 3452 - 3459
  • [7] Structural aberrations affecting the MYC locus indicate a poor prognosis independent of clinical risk factors in diffuse large B-cell lymphomas treated within randomized trials of the German High-Grade Non-Hodgkin's Lymphoma Study Group (DSHNHL)
    Klapper, W.
    Stoecklein, H.
    Zeynalova, S.
    Ott, G.
    Kosari, F.
    Rosenwald, A.
    Loeffler, M.
    Truemper, L.
    Pfreundschuh, M.
    Siebert, Reiner
    [J]. LEUKEMIA, 2008, 22 (12) : 2226 - 2229
  • [8] MYC rearrangements are useful for predicting outcomes following rituximab and chemotherapy: multicenter analysis of Japanese patients with diffuse large B-cell lymphoma
    Kojima, Minoru
    Nishikii, Hidekazu
    Takizawa, Jun
    Aoki, Sadao
    Noguchi, Masayuki
    Chiba, Shigeru
    Ando, Kiyoshi
    Nakamura, Naoya
    [J]. LEUKEMIA & LYMPHOMA, 2013, 54 (10) : 2149 - 2154
  • [9] MYC gene rearrangements are associated with a poor prognosis in diffuse large B-cell lymphoma patients treated with R-CHOP chemotherapy
    Savage, Kerry J.
    Johnson, Nathalie A.
    Ben-Neriah, Susana
    Connors, Joseph M.
    Sehn, Laurie H.
    Farinha, Pedro
    Horsman, Douglas E.
    Gascoyne, Randy D.
    [J]. BLOOD, 2009, 114 (17) : 3533 - 3537
  • [10] Plasmablastic lymphoma with MYC translocation: evidence for a common pathway in the generation of plasmablastic features
    Taddesse-Heath, Lekidelu
    Meloni-Ehrig, Aurelia
    Scheerle, Jay
    Kelly, JoAnn C.
    Jaffe, Elaine S.
    [J]. MODERN PATHOLOGY, 2010, 23 (07) : 991 - 999
1